Francis Patrick Ostronic, Director at Cyclo Therapeutics, Inc. (CYTH), bought 10,000 shares at $6.30 ($65K) on 2021-04-16, disclosed to the SEC on 2021-04-16.
Open-market purchase of $65k CYTH by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.30 | 5,000 | $32K | 48.3% |
| 2 | $6.75 | 5,000 | $34K | 51.7% |
| Total | $6.53 avg | 10,000 | $65K | 100% |
| Filing → |
| CYTH | BUY | 2022-05-23 | $10K | — | Filing → |
| CYTH | BUY | 2022-01-24 | $8K | — | Filing → |
| CYTH | BUY | 2022-01-19 | $5K | — | Filing → |